MedTrace Logo

CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany

NCT04659187 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2020-12-17

No results posted yet for this study

Summary

This is a multicenter, observational, prospective, epidemiological cohort study at 45 hospitals in Germany, all part of a German hospital network. All hospitalized patients tested positive for SARS-CoV-2 will be included.

Conditions

Sponsors & Collaborators

  • Asklepios Kliniken GmbH & Co. KGaA

    collaborator UNKNOWN

  • Asklepios proresearch

    lead INDUSTRY

Principal Investigators

  • Christoph U Herborn, Prof. MD · Asklepios Kliniken GmbH & Co. KGaA

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-26
Primary Completion
2021-05-30
Completion
2021-07-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04659187 on ClinicalTrials.gov